Published in PLoS One on September 01, 2015
Development and Implementation of Culturally Tailored Offline Mobile Health Surveys. JMIR Public Health Surveill (2016) 0.77
Characterization of cervical cancer stem cell-like cells: phenotyping, stemness, and human papilloma virus co-receptor expression. Oncotarget (2016) 0.76
Research Capacity at Traditional Chinese Medicine (TCM) Centers in China: A Survey of Clinical Investigators. Evid Based Complement Alternat Med (2017) 0.75
The Landscape of Randomised Controlled Trials of Therapies in Breast Cancer in Low and Middle Income Countries. Int J Breast Cancer (2017) 0.75
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med (2009) 35.37
Priority actions for the non-communicable disease crisis. Lancet (2011) 15.18
The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA (2004) 8.25
Scoping studies: advancing the methodology. Implement Sci (2010) 7.82
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet (2011) 7.71
Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet (2010) 6.84
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol (2012) 6.37
Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine (2008) 4.82
Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol (2005) 3.16
Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health (2008) 2.86
Chapter 8: Screening for cervical cancer in developing countries. Vaccine (2006) 2.35
Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis. Int J Surg (2006) 2.33
Governance challenges in global health. N Engl J Med (2013) 2.33
Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer (2008) 2.30
A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet (2005) 2.27
Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynaecol Obstet (2011) 2.01
Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer (2008) 1.90
Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J (2006) 1.85
Visual inspection methods for cervical cancer prevention. Best Pract Res Clin Obstet Gynaecol (2011) 1.85
Breast cancer early detection methods for low and middle income countries, a review of the evidence. Breast (2012) 1.82
Breast cancer issues in developing countries: an overview of the Breast Health Global Initiative. World J Surg (2008) 1.67
Tackling non-communicable diseases in low- and middle-income countries: is the evidence from high-income countries all we need? PLoS Med (2013) 1.67
Global cancer patterns: causes and prevention. Lancet (2013) 1.67
Breast pathology guideline implementation in low- and middle-income countries. Cancer (2008) 1.61
Experience using cryotherapy for treatment of cervical precancerous lesions in low-resource settings. Int J Gynaecol Obstet (2005) 1.57
Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds? Ann Med (2011) 1.54
A million africans a year dying from cancer by 2030: what can cancer research and control offer to the continent? Int J Cancer (2011) 1.54
Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Cancer Prev Res (Phila) (2011) 1.50
Breast cancer in Brazil: present status and future goals. Lancet Oncol (2012) 1.49
Evidence-based public health: what does it offer developing countries? J Public Health (Oxf) (2005) 1.46
Reducing HPV-associated cancer globally. Cancer Prev Res (Phila) (2012) 1.46
Breast cancer in limited-resource countries: early detection and access to care. Breast J (2006) 1.43
Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy. Int J Cancer (2011) 1.41
Breast cancer management in low resource countries (LRCs): consensus statement from the Breast Health Global Initiative. Breast (2011) 1.39
Breast cancer in limited-resource countries: health care systems and public policy. Breast J (2006) 1.35
HPV & HPV vaccination: issues in developing countries. Indian J Med Res (2009) 1.35
Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review. Vaccine (2013) 1.31
HIV and cancer of the cervix. Best Pract Res Clin Obstet Gynaecol (2005) 1.27
Delivering cervical cancer prevention services in low-resource settings. Int J Gynaecol Obstet (2005) 1.26
Breast cancer in Mexico: a growing challenge to health and the health system. Lancet Oncol (2012) 1.19
Cervical cancer: prevention and treatment. Discov Med (2012) 1.18
Cervical cancer screening and prevention in low-resource settings. Clin Obstet Gynecol (2013) 1.16
Exporting 'failure': why research from rich countries may not benefit the developing world. Rev Saude Publica (2010) 1.16
Overview of cervical cancer in the developing world. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 1.12
Preventing cervical cancer in low-resource settings: how far have we come and what does the future hold? Int J Gynaecol Obstet (2005) 1.10
Locally advanced breast cancer: treatment guideline implementation with particular attention to low- and middle-income countries. Cancer (2008) 1.10
Women's cancers in developing countries: from research to an integrated health systems approach. Asian Pac J Cancer Prev (2009) 1.10
The prevention of cervical cancer in developing countries. BJOG (2005) 1.10
Cervical cancer prevention--cervical screening: science in evolution. Obstet Gynecol Clin North Am (2007) 1.07
Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocation. Cancer (2008) 1.07
Screening for cervical cancer in the developing world. Best Pract Res Clin Obstet Gynaecol (2005) 1.06
Breast cancer in limited-resource countries: diagnosis and pathology. Breast J (2006) 1.05
Biomarkers for the clinical management of breast cancer: international perspective. Int J Cancer (2013) 1.04
Chapter 26: Innovative financing mechanisms to accelerate the introduction of HPV vaccines in developing countries. Vaccine (2006) 1.02
Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries. Immunotherapy (2009) 1.01
Efficacy, safety, acceptability and affordability of cryotherapy: a review of current literature. Minerva Ginecol (2012) 0.99
Implementation of human papillomavirus immunization in the developing world. Vaccine (2012) 0.99
HPV vaccination: the promise & problems. Indian J Med Res (2009) 0.99
Evidence-based screening, early diagnosis and treatment strategy of cervical cancer for national policy in low- resource countries: example of India. Asian Pac J Cancer Prev (2012) 0.98
Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence. Sex Health (2010) 0.97
Cervical cancer and the global health agenda: Insights from multiple policy-analysis frameworks. Glob Public Health (2013) 0.96
Women's perspectives on cervical screening and treatment in developing countries: experiences with new technologies and service delivery strategies. Women Health (2006) 0.95
Are treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic review. BMC Womens Health (2010) 0.95
HPV vaccines. Best Pract Res Clin Obstet Gynaecol (2005) 0.92
Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast (2013) 0.92
Economic analyses of breast cancer control in low- and middle-income countries: a systematic review. Syst Rev (2013) 0.92
Cytological screening for cervical cancer prevention. Best Pract Res Clin Obstet Gynaecol (2011) 0.92
Breast cancer management in middle-resource countries (MRCs): consensus statement from the Breast Health Global Initiative. Breast (2011) 0.91
Home monitoring of blood glucose (HMBG) in Type-2 diabetes mellitus in a developing country. Diabetes Res Clin Pract (1999) 0.91
The role of cancer research in noncommunicable disease control. J Natl Cancer Inst (2012) 0.91
Cervical cancer screening in India: strategies revisited. Indian J Med Sci (2007) 0.91
Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries. Med Oncol (2013) 0.90
Guideline implementation for breast healthcare in low- and middle-income countries: breast healthcare program resource allocation. Cancer (2008) 0.90
Breast cancer in low and middle income countries (LMICs): a shifting tide in global health. Breast J (2014) 0.89
Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa. Vaccine (2013) 0.89
Breast radiation therapy guideline implementation in low- and middle-income countries. Cancer (2008) 0.89
Low cost methods for secondary prevention of cervical cancer in developing countries. Niger Postgrad Med J (2007) 0.89
Challenges in the management of breast cancer in low- and middle-income countries. Future Oncol (2012) 0.88
Prophylactic HPV vaccination: a major breakthrough in the fight against cervical cancer? Minerva Med (2009) 0.87
Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol (2009) 0.87
Social determinants of health associated with cervical cancer screening among women living in developing countries: a scoping review. Arch Gynecol Obstet (2012) 0.87
Breast cancer screening in developing countries. Best Pract Res Clin Obstet Gynaecol (2012) 0.87
Improving access to surgery in a developing country: experience from a surgical collaboration in Sierra Leone. J Surg Educ (2010) 0.86
Upgrading public health programs for human papillomavirus prevention and control is possible in low- and middle-income countries. Vaccine (2012) 0.86
Advocating for cervical cancer prevention. Int J Gynaecol Obstet (2005) 0.86
Alternative approaches to cervical cancer screening for developing countries. Best Pract Res Clin Obstet Gynaecol (2012) 0.86
Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP. Global Health (2009) 0.85
Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer. Br J Cancer (2007) 0.85
SOGC–GOC–SCC Joint Policy Statement. No. 255, March 2011. Cervical cancer prevention in low-resource settings. J Obstet Gynaecol Can (2011) 0.84
Cervical cancer and HPV vaccines in developing countries. Asian Pac J Cancer Prev (2009) 0.84
Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol (2009) 0.84
Guideline implementation for breast healthcare in low- and middle-income countries: diagnosis resource allocation. Cancer (2008) 0.83
Human papillomavirus vaccination in low-resource countries: lack of evidence to support vaccinating sexually active women. Br J Cancer (2012) 0.83
Cervical cancer screening in high- and low-resource countries: implications and new developments. Obstet Gynecol Surv (2012) 0.83
HPV vaccine acceptability in Africa: a systematic review. Prev Med (2014) 0.83
Implementing sentinel lymph node biopsy programs in developing countries: challenges and opportunities. World J Surg (2011) 0.82
Cancer transition and priorities for cancer control. Lancet Oncol (2012) 0.82
Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines. Best Pract Res Clin Obstet Gynaecol (2011) 0.82
Diet and breast cancer. Salud Publica Mex (2012) 0.82